Blog

DuPont de Nemours, Inc. DD has registered a fourth-quarter 2025 loss from continuing operations of $108 million or 27 cents per share. In the year-ago quarter, the company recorded a loss of $291

Zimmer Biomet Holdings, Inc. ZBH posted fourth-quarter 2025 adjusted earnings per share (EPS) of $2.42, which beat the Zacks Consensus Estimate by 1.7%. The adjusted figure rose 4.8% year over year.

Eli Lilly LLY announced that it entered a definitive agreement to acquire the privately held clinical-stage biotech Orna Therapeutics in a deal valued at $2.4 billion. This transaction includes both

Equinor ASA EQNR signed a five-year gas supply deal with Dutch gas grid operator Eneco to supply natural gas to the Netherlands. Per the terms of the deal, Equinor will deliver up to 0.5 billion

Bristol Myers’ BMY legacy portfolio — comprising Eliquis, Revlimid, Pomalyst, Sprycel and Abraxane — continues to face significant erosion from generic competition.

Fourth-quarter legacy portfolio

Goodyear Tire GT reported fourth-quarter 2025 adjusted earnings per share of 39 cents, which missed the Zacks Consensus Estimate of 45 cents. The company reported earnings of 39 cents per share in

Harley-Davidson, Inc. HOG reported a loss of $2.44 per share in fourth-quarter 2025, wider than the Zacks Consensus Estimate of a loss of 92 cents. The company had incurred a loss of 93 cents per

Ashland Inc. ASH announced that its agrimer eco-coat polymer seed coating for crop care has been officially posted and approved by the United States Environmental Protection Agency. The new

Sally Beauty Holdings, Inc. SBH reported fiscal first-quarter 2026 results, wherein the top line came slightly below the Zacks Consensus Estimate, while the bottom line beat the Zacks Consensus

Advanced Micro Devices AMD shares have plunged 11% post fourth-quarter 2025 reported on Feb. 3. The company reported non-GAAP earnings of $1.53 per share, which jumped 40.4% year over year and 27.5%

nVent Electric NVT shares have gained 2% since the company reported its fourth-quarter 2025 earnings on Feb. 6. The rise was driven by the strength in data center demand, infrastructure growth

T. Rowe Price Group, Inc. TROW board of directors announced a quarterly dividend of $1.30 per share, representing a 2.4% increase from the prior payout. The dividend will be paid out on March 30

Eli Lilly and Company LLY announced fourth-quarter and full-year results last week. The company delivered robust financial performance in 2025 with revenues of $65.2 billion rising 45% and EPS

We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its fourth-quarter and full-year 2025 results on Feb. 12, after market close. The Zacks Consensus Estimate for the

International Business Machines Corporation’s IBM QRadar Security Information and Event Management (SIEM) and Security Orchestration, Automation and Response (SOAR) platforms have been integrated

Quest Diagnostics Inc.’s DGX fourth-quarter 2025 adjusted earnings per share (EPS) of $2.42 beat the Zacks Consensus Estimate by 2.85%. The metric also exceeded the year-ago adjusted figure by 8.5%.

Sanofi SNY announced that the FDA has granted Breakthrough Therapy designation to Wayrilz (rilzabrutinib), a novel oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor, for the treatment of

Stocks hitting their 52-week high and delivering consistent performance offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived

CNA Financial Corporation CNA reported fourth-quarter 2025 core earnings of $1.16 per share, which missed the Zacks Consensus Estimate by 3.3%. The bottom line decreased 7.2% year over year.The

Salesforce, Inc. CRM shares have plunged 16.8% over the past six months, underperforming the broader Zacks Computer and Technology sector’s gain of 10.8%.

The sharp contrast raises a tough question

Kimco Realty Corporation KIM is slated to report fourth-quarter 2025 results on Feb. 12, before the opening bell. The company’s quarterly results are likely to display year-over-year growth in

Incyte Corporation INCY reported fourth-quarter 2025 adjusted earnings of $1.80 per share, which missed the Zacks Consensus Estimate of $1.94, primarily due to higher operating expenses. The company

Tuesday, February 10th, 2026Pre-market indexes are pulling back slightly this morning, following another record close from the blue-chip Dow on Monday. Spirits are generally higher than they were

Masco Corporation MAS posted mixed fourth-quarter 2025 results, wherein the adjusted earnings surpassed the Zacks Consensus Estimate, while net sales missed the same. Both metrics tumbled on a